CVRx® Closes $12 Million Additional Financing

by Ysios Capital

Minneapolis – October 30, 2013 – CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the ...

Read more

AB-Biotics acquires a patent for predicting antipsychotic-induced extrapyramidal symptoms

by AB-BIOTICS
  • 13 years ago

The method will be incorporated into Neurofarmagen, a genetic test which helps doctors identify the most appropriate treatment for each neuropsychiatric patient

Read more

Expert investigators from Pangaea Biotech S.L are co-authors of results presented at the 2013 World Lung Cancer Congress (WCLC).

by Pangaea Biotech

Results presented include analyses of predictive biomarkers and novel mechanisms of resistance to targeted therapies, as well as the early results of whole exome and transcriptome sequencing in col...

Read more

ApliClinics project's results will be presented at the Clinical Genomics and Informatics conference organized by Bio-IT World and Cambridge Healthtech Institute

by Integromics

On February 2, 2012 it was announced that Integromics®, a market leader in IT solutions provision for life sciences in the field of genomics and proteomics, entered into a partnership with Professo...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Oryzon recibe el Premio Pyme del Año 20...

by Oryzon Genomics

El galardón convierte a Oryzon en una de las cinco ganadoras de la pr...

Photos Stream